Replies to post #231332 on Amfil Technologies Inc (FUNN)

[mjfrank]

Lots of folks said the same thing about the multi year FY2015/16/17 audit. Even went as far as to say it was “never ending”

Then one morning there it was..

Filed with OTC.

No complaints here as FY2018 audit will be done just the same and one morning we’ll wake up and it will also be filed on OTC market.

[Juancy]

I would worry about it at the right time. Right now Q4 2019 is not in the books yet so let's not put the cart before the horse. It is times like these when investors look over their pros and cons checklist.

My cons:

1) Audit delay.
2) Lack of fins for a year.
3) News that have not materialized.

My pros:

1) Fundamentals are still intact.
2) Multimillions in revenues.
3) Evidence of growth with S&L division.
4) No toxic lending.
5) Audit being done to gain credibility.
6) Compassionate and determined CEO.
7) Plans for spin-off and free divies.

I still prefer my positives and understand that this is a high risk, high reward Pink stock with clearly more upside. The bigger picture is definitely more enticing to me. GLTA! :-)

$AMFE